Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Other Non-Current Assets (2016 - 2025)

Ligand Pharmaceuticals' Other Non-Current Assets history spans 16 years, with the latest figure at $2.8 million for Q3 2025.

  • For Q3 2025, Other Non-Current Assets fell 67.03% year-over-year to $2.8 million; the TTM value through Sep 2025 reached $2.8 million, down 67.03%, while the annual FY2024 figure was $6.9 million, 8.32% up from the prior year.
  • Other Non-Current Assets for Q3 2025 was $2.8 million at Ligand Pharmaceuticals, down from $9.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $11.9 million in Q2 2024 and bottomed at $1.7 million in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $6.3 million (2022), against an average of $6.0 million.
  • The largest annual shift saw Other Non-Current Assets surged 268.2% in 2023 before it crashed 67.03% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.7 million in 2021, then tumbled by 36.67% to $1.7 million in 2022, then soared by 268.2% to $6.4 million in 2023, then increased by 8.32% to $6.9 million in 2024, then tumbled by 59.98% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Other Non-Current Assets are $2.8 million (Q3 2025), $9.1 million (Q2 2025), and $7.9 million (Q1 2025).